1. Home
  2. BGLC vs NVOS Comparison

BGLC vs NVOS Comparison

Compare BGLC & NVOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BGLC
  • NVOS
  • Stock Information
  • Founded
  • BGLC 2017
  • NVOS 2000
  • Country
  • BGLC Malaysia
  • NVOS United States
  • Employees
  • BGLC N/A
  • NVOS N/A
  • Industry
  • BGLC Medical Specialities
  • NVOS Assisted Living Services
  • Sector
  • BGLC Health Care
  • NVOS Health Care
  • Exchange
  • BGLC Nasdaq
  • NVOS Nasdaq
  • Market Cap
  • BGLC 7.6M
  • NVOS 5.6M
  • IPO Year
  • BGLC N/A
  • NVOS 2017
  • Fundamental
  • Price
  • BGLC $0.37
  • NVOS $0.22
  • Analyst Decision
  • BGLC
  • NVOS
  • Analyst Count
  • BGLC 0
  • NVOS 0
  • Target Price
  • BGLC N/A
  • NVOS N/A
  • AVG Volume (30 Days)
  • BGLC 117.9K
  • NVOS 326.0K
  • Earning Date
  • BGLC 11-20-2024
  • NVOS 12-12-2024
  • Dividend Yield
  • BGLC N/A
  • NVOS N/A
  • EPS Growth
  • BGLC N/A
  • NVOS N/A
  • EPS
  • BGLC N/A
  • NVOS N/A
  • Revenue
  • BGLC $9,183,168.00
  • NVOS $13,516,958.00
  • Revenue This Year
  • BGLC N/A
  • NVOS N/A
  • Revenue Next Year
  • BGLC N/A
  • NVOS N/A
  • P/E Ratio
  • BGLC N/A
  • NVOS N/A
  • Revenue Growth
  • BGLC N/A
  • NVOS 1102.98
  • 52 Week Low
  • BGLC $0.31
  • NVOS $0.20
  • 52 Week High
  • BGLC $3.39
  • NVOS $3.45
  • Technical
  • Relative Strength Index (RSI)
  • BGLC 32.80
  • NVOS 35.38
  • Support Level
  • BGLC $0.38
  • NVOS $0.20
  • Resistance Level
  • BGLC $0.49
  • NVOS $0.31
  • Average True Range (ATR)
  • BGLC 0.02
  • NVOS 0.03
  • MACD
  • BGLC -0.01
  • NVOS 0.00
  • Stochastic Oscillator
  • BGLC 5.94
  • NVOS 18.64

About BGLC BioNexus Gene Lab Corp Common stock

BioNexus Gene Lab Corp through its wholly owned subsidiary, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. In addition, the Company is in the business of developing and providing safe, effective, and non-invasive liquid biopsy tests for the early detection of biomarkers that it believes are linked to diseases to minimize treatment costs and improve patient management. Its non-invasive blood tests provide analysis of changes in RNA to detect the potential risk of 11 different diseases.

About NVOS Novo Integrated Sciences Inc.

Novo Integrated Sciences Inc is a medical care company. It provides specialized physiotherapy, chiropractic care, occupational therapy, eldercare, laser therapeutics, massage therapy, acupuncture, neurological functions, kinesiology, and others. It has two reportable segments: healthcare services which generates majority of the revenue, and product sales.

Share on Social Networks: